RxDoctor Payments DataLook up a doctor →

Joseph Wanzek, DO

Family Medicine · Council Bluffs, IANPI 1164538674

Payments from drug & device makers

$12,813in general payments, 2019–2025

Across 764 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$930
  • Mylan Specialty L.p.$550
  • Novo Nordisk$512
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)121$1,947
AstraZeneca66$1,357
Lilly USA, LLC75$1,109
Pfizer61$930
Mylan Specialty L.p.34$550
Novo Nordisk31$512
Lundbeck LLC26$491
Takeda Pharmaceuticals U.S.A., Inc.30$461
Amgen29$455
Otsuka America Pharmaceutical, Inc.24$394
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$386
Johnson & Johnson27$365
Merck23$337
Bayer18$278
Boehringer Ingelheim17$264
Aimmune Therapeutics, Inc.3$241
Nestle Healthcare Nutrition Inc.6$197
GSK13$189
Almatica Pharma LLC10$185
Biohaven Pharmaceutical Holding Company Ltd.10$152
Axsome Therapeutics, Inc.7$125
Actelion Pharmaceuticals US, Inc.3$122
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$103
Philips North America LLC5$95
Idorsia Pharmaceuticals US Inc6$93
Vanda Pharmaceuticals Inc.3$84
Astellas Pharma US Inc5$82
Sunovion Pharmaceuticals Inc.10$81
Xeris Pharmaceuticals, Inc.4$71
Inspire Medical Systems, Inc.2$69
Sumitomo Pharma America, Inc.3$69
Viatris Specialty LLC4$69
Phathom Pharmaceuticals, Inc.8$68
Supernus Pharmaceuticals, Inc.4$68
Optinose US, Inc.4$66
Avanir Pharmaceuticals, Inc.3$53
E.r. Squibb & Sons, L.L.C.4$53
Radius Health, Inc.2$52
Teva Pharmaceuticals USA, Inc.3$47
Exact Sciences3$44
Seqirus USA Inc2$38
Kowa Pharmaceuticals America, Inc.3$38
Jazz Pharmaceuticals Inc.2$34
Bristol Myers Squibb2$30
Sanofi-aventis U.S. LLC2$28
Biohaven Pharmaceuticals, Inc.1$28
Alkermes, Inc.1$27
Eisai Inc.2$27
Tonix Medicines, Inc.1$26
Azurity Pharmaceuticals, Inc.1$23
Amarin Pharma, Inc.1$22
Abbott1$21
Abiomed1$21
Forte Bio-pharma LLC1$21
Collegium Pharmaceutical, Inc.1$18
Ultragenyx Pharmaceutical Inc.1$18
Genentech USA, Inc.1$17
Paratek Pharmaceuticals, Inc.1$16
Nabriva Therapeutics, PLC1$16
Verona Pharma, Inc.1$16

How this compares

$12,813 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$66,579
Medicare patients
180
Services billed
1,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Council Bluffs

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →